Attention Deficit Hyperactivity Disorder (ADHD) News and Research

RSS

Attention Deficit Hyperactivity Disorder (ADHD)

Attention deficit-hyperactivity disorder (ADHD) is a neurobehavioral disorder that affects 3-5 percent of all American children. It interferes with a person's ability to stay on a task and to exercise age-appropriate inhibition (cognitive alone or both cognitive and behavioral).

"Extremely preterm children" at higher risk for later psychiatric disorders

Significant advances in the neonatal intensive care have resulted in increased survival rates of children who are born at less than 26 weeks of gestation, so termed "extremely preterm children". Notably, however, improved survival rates have been accompanied by a higher risk for later cognitive, neuromotor, and sensory impairments in these children.

24 Apr 2010

Study finds prevalence of psychiatric disorders in extremely preterm survivors

24 Apr 2010

Hearing tests needed for children

The importance of hearing testing isn't widely understood by many parents. Parents may schedule appointments with an opthamologist for an eye exam for their children at regular intervals - but never think to similarly schedule a hearing test with an audiologist.

21 Apr 2010

Unwarranted increase in use of psychotropic medications for children

A new study from the Journal of Marital & Family Therapy warns of the dramatic rise in the use of psychotropic medications for children. One in every fifty Americans is now considered permanently disabled by mental illness, and up to eight million children take one or more psychotropic drugs.

21 Apr 2010

When does your child really need medication?

When does your child really need medication? A frightening number of parents are medicating their young children today. Many parents are considering medication for Obsessive-Compulsive Disorder (OCD) and for those children showing signs of Attention Deficit Hyperactivity Disorder (ADHD). Journalist Louis Theroux is taking a television viewers on an investigative journey through children who are under medication to modify their behavior.

21 Apr 2010

ADHD behaviors in children associated with serotonin activity and self-blame

ADHD may be caused by alterations in the serotonin neurotransmission system combined with a tendency to experience psychosocial distress. Researchers writing in BioMed Central's open access journal Behavioral and Brain Functions found that ADHD behaviors in children and adolescents were associated with interactions between low and high serotonin activity and self-blame in relation to inter-parental conflict.

17 Apr 2010

Medication and behaviour therapy help children with Attention Deficit Hyperactivity Disorder

Medication and behavioural interventions help children with Attention Deficit Hyperactivity Disorder (ADHD) better maintain attention and self control by normalising activity in the same brain systems, according to researchers at The University of Nottingham.

15 Apr 2010

Stimulant medication normalizes brain function in children with ADHD: Study

Attention-deficit/hyperactivity disorder is one of the most common mental health disorders affecting children and adolescents. Children with ADHD are excessively restless, impulsive, and distractible and experience difficulties at home and in school. Problems inhibiting behavior are a common theme for ADHD symptoms.

7 Apr 2010

Britain popping “pills for every ill”, says research

A new study reports that Britons are turning to prescription drugs for every illness, minor or major. This recent paper titled “A Pill for Every Ill”, published in Social Science & Medicine journal says that while two decades earlier average number of prescriptions dispensed per person was only eight, it is more than 16 now.

30 Mar 2010

Cortex signs agreement to sell certain AMPAKINE compounds to Biovail

Cortex Pharmaceuticals, Inc. announced that it has entered into an agreement with Biovail Laboratories International SRL in which Biovail acquired certain AMPAKINE compounds and the rights to the patent filing for respiratory depression and vaso-occlusive crises associated with sickle cell disease.

29 Mar 2010

Minority children in the U.S. face pervasive gap in quality and extent of health care

Minority children in the U.S. face a pervasive gap in the quality and extent of health care received compared to Caucasians, according to a report from the American Academy of Pediatrics written by a UT Southwestern Medical Center physician.

29 Mar 2010

BeaconEquity.com announces investment report featuring Intellipharmaceutics International

BeaconEquity.com announces an investment report featuring Intellipharmaceutics International Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.

16 Mar 2010

Fluoride chemicals may increase lead accumulation, say researchers

Fluoride chemicals added to public water supplies, boosts lead absorption in lab animals' bones, teeth and blood, report Sawan, et al. (Toxicology 2/2010). Earlier studies already show children's blood-lead-levels are higher in fluoridated communities, reports Sawan's research team.

16 Mar 2010

Generic Focalin XR patent suit: Intellipharmaceutics International announces settlement

Intellipharmaceutics International Inc. today announced that Novartis Pharmaceuticals Corporation and Celgene Corporation have settled their patent suit in the U.S. District Court for the District of New Jersey, and Elan Pharma International Ltd. has settled its patent suit in the U.S. District Court for the District of Delaware, with Intellipharmaceutics Corp., a wholly-owned subsidiary of Intellipharmaceutics International, and its licensee Par Pharmaceutical, Inc. over a generic version of the Attention Deficit Hyperactivity Disorder drug Focalin XR® (dexmethylphenidate hydrochloride).

12 Mar 2010

ADHD News Network Broadcast wins Shire and P2M coveted 2010 Telly Award

After reviewing more than 13,000 entries, the Telly Awards® and their Silver Council announced the Shire and PharmtoMarket (P2M) produced "ADHD News Network Broadcast: 11/18/2009" had received the coveted 2010 Telly Award for video broadcasting and production.

10 Mar 2010

Study suggests early warning signs for autism spectrum disorders within families

A new study suggests a trend toward developing hyperactivity among typically developing elementary-school-aged siblings of autistic preschoolers and supports the notion that mothers of young, autistic children experience more depression and stress than mothers with typically developing children.

9 Mar 2010

FDA's 5-year NCE exclusivity grant to VYVANSE: Court upholds decision

Shire plc, the global specialty biopharmaceutical company, announces that the United States District Court for the District of Columbia ("Court"), following extensive briefing by the parties and an oral hearing, has upheld the decision of the U.S. Food and Drug Administration ("FDA") to grant 5-year New Chemical Entity ("NCE") exclusivity to lisdexamfetamine dimesylate-currently marketed by Shire U.S. Inc. for the treatment of attention-deficit hyperactivity disorder under the name VYVANSE(R).

5 Mar 2010

Shire reports total revenues of $3,008 million for 2009

Shire plc the global specialty biopharmaceutical company, announces results for the year to December 31, 2009.

22 Feb 2010

HHMI investigator to discuss how brain creates and controls emotions

Scientists know little about how the brain creates and controls emotions - an uncertainty that presents a major obstacle in the effort to develop treatments for emotional disorders. "The study of the brain science of emotion is in its infancy," says Howard Hughes Medical Institute (HHMI) investigator David Anderson, "yet emotional and psychiatric disorders continue to take an enormous toll on human society."

22 Feb 2010

Tips for Parenting ADHD Kids: Free seminar to educate and support parents of children with ADHD

The Learning Lab of Brentwood will present a free seminar, Tips for Parenting ADHD Kids, on Thursday February 25 from 12:00-1:30 PM at the Community Services Building in Franklin. Dr. David Elkins, Clinical Psychologist and Supervising Psychologist of the Assessment Center at The Learning Lab of Brentwood, will lead the seminar.

18 Feb 2010